Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bu-Shen Jian-Gu formulation is a Traditional Chinese Medicine (TCM) herbal therapy developed for the treatment of bone-related disorders, specifically diabetic osteoporosis. Based on the TCM principle of 'Kidney governing bone and generating marrow,' the formulation aims to tonify the kidney essence to improve bone mineral density and microarchitecture. It is typically administered as an oral decoction or granule. Clinical research, such as trials conducted by the Gansu Provincial Hospital of Traditional Chinese Medicine, evaluates its efficacy in improving bone metabolism markers and reducing symptoms in patients with diabetic osteoporosis compared to standard treatments like Calcium D.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Jiangu formulation.